Annotation Detail

Information
Associated Genes
ALB
Associated Variants
ALB MUTATION
ALB MUTATION
Associated Disease
Carcinoma breast stage IV
Source Database
DisGeNET
Description
A prospective, multicenter trial was undertaken to assess the activity, safety, and quality of life of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer (MBC).
Pubmed
25931813
Section of the abstract supporting the evidence
BACKGROUND
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
1
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000542883744160607
Drugs